Does METHYLDOPA Cause Foetal growth restriction? 172 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 172 reports of Foetal growth restriction have been filed in association with METHYLDOPA (Methyldopa). This represents 6.6% of all adverse event reports for METHYLDOPA.
172
Reports of Foetal growth restriction with METHYLDOPA
6.6%
of all METHYLDOPA reports
9
Deaths
53
Hospitalizations
How Dangerous Is Foetal growth restriction From METHYLDOPA?
Of the 172 reports, 9 (5.2%) resulted in death, 53 (30.8%) required hospitalization, and 3 (1.7%) were considered life-threatening.
Is Foetal growth restriction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLDOPA. However, 172 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLDOPA Cause?
Foetal exposure during pregnancy (1,028)
Premature baby (792)
Maternal exposure during pregnancy (623)
Premature delivery (519)
Exposure during pregnancy (502)
Low birth weight baby (350)
Drug ineffective (162)
Live birth (153)
Off label use (152)
Pre-eclampsia (110)
What Other Drugs Cause Foetal growth restriction?
ASPIRIN (414)
PREDNISOLONE (269)
PREDNISONE (222)
AZATHIOPRINE (200)
ENOXAPARIN (198)
TACROLIMUS (184)
HYDROXYCHLOROQUINE (178)
DEXAMETHASONE (172)
METHYLPREDNISOLONE (168)
BISOPROLOL (163)
Which METHYLDOPA Alternatives Have Lower Foetal growth restriction Risk?
METHYLDOPA vs METHYLENE BLUE
METHYLDOPA vs METHYLENEDIOXYPYROVALERONE
METHYLDOPA vs METHYLERGONOVINE
METHYLDOPA vs METHYLNALTREXONE
METHYLDOPA vs METHYLPHENIDATE